4.6 Article

TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Biochemistry & Molecular Biology

Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update

Mayra Colardo et al.

Summary: Gliomas are the most common and challenging malignant tumors of the central nervous system, with limited treatment efficacy and the development of resistance leading to tumor recurrence. Therefore, finding effective and well-tolerated pharmacological approaches is crucial in combating this disease.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Oncology

Inhibition of Cathepsin S Restores TGF-β-induced Epithelial-to-mesenchymal Transition and Tight Junction Turnover in Glioblastoma Cells

Li Wei et al.

Summary: The study revealed a correlation between high CTSS expression and glioma tissue grades, with CTSS inhibitor ZFL attenuating TGF-beta-induced invasive growth. Inhibition of CTSS reversed TGF-beta-induced epithelial-to-mesenchymal transition and restored the turnover of tight junction proteins, leading to decreased mobility of glioblastoma cells. Furthermore, the PI3K/AKT/mTOR pathway was found to be suppressed in the TGF-beta+ZFL groups, highlighting its importance in this process.

JOURNAL OF CANCER (2021)

Article Biotechnology & Applied Microbiology

A comprehensive enhancer screen identifies TRAM2 as a key and novel mediator of YAP oncogenesis

Li Li et al.

Summary: YAP, a transcription co-factor, binds to thousands of enhancer loci to stimulate tumor aggressiveness. Through unbiased functional approaches, researchers identified and characterized TRAM2 as a novel mediator of cellular proliferation, migration, and invasion induced by YAP. These findings help elucidate the mechanisms by which YAP promotes cancer aggressiveness and may aid in cancer metastasis diagnosis.

GENOME BIOLOGY (2021)

Review Oncology

Brain malignancies: Glioblastoma and brain metastases

Tamara T. Lah et al.

SEMINARS IN CANCER BIOLOGY (2020)

Review Oncology

Management of glioblastoma: State of the art and future directions

Aaron C. Tan et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Biochemistry & Molecular Biology

Targeting PI3K in cancer: mechanisms and advances in clinical trials

Jing Yang et al.

MOLECULAR CANCER (2019)

Review Oncology

PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside

Ali S. Alzahrani

SEMINARS IN CANCER BIOLOGY (2019)

Review Pharmacology & Pharmacy

EMT: Mechanisms and therapeutic implications

Mohini Singh et al.

PHARMACOLOGY & THERAPEUTICS (2018)

Article Clinical Neurology

Current Concepts and Management of Glioblastoma

Matthias Preusser et al.

ANNALS OF NEUROLOGY (2011)

Article Oncology

TRAM1 is involved in disposal of ER membrane degradation substrates

Caroline L. Ng et al.

EXPERIMENTAL CELL RESEARCH (2010)

Article Biochemistry & Molecular Biology

Identification of novel Runx2 targets in osteoblasts:: Cell type-specific BMP-dependent regulation of Tram2

Steven Pregizer et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2007)

Article Biochemistry & Molecular Biology

TRAM2 protein interacts with endoplasmic reticulum Ca2+ pump Serca2b and is necessary for collagen type I synthesis

B Stefanovic et al.

MOLECULAR AND CELLULAR BIOLOGY (2004)